0 results available. Select is focused ,type to refine list, press Down to open the menu,
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...
The following section summarizes insights on Insulet Corporation's Return on Invested Capital:
Data is returned as a standard number. Suggested format is percent (e.g 0.171 => 17.1%). Please note, you need a Premium subscription to access data for roic.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Return on Invested Capital in the efficiency category include:
A capital efficiency ratio used to measure a firm's ability to create value for all its stakeholders, debt, and equity.
Return on Invested Capital or ROIC is defined as:
Net Operating Profit After Tax
(/) Average Invested Capital
Return on Invested Capital
Return on Invested Capital for Insulet is calculated as follows:
Net Operating Profit After Tax [ $256.4 M ]
(/) Average Invested Capital over Period [ $2.414 B ]
(=) Return on Invested Capital [ 10.6% ]
Where Invested Capital is calculated as follows:
(+) Average debt = ($1.449 B + $1.434 B) / 2 = $1.442 B
(+) Average Equity = ($732.7 M + $1.212 B) / 2 = $972.1 M
(=) Invested Capital [ $2.414 B ]
The tables below summarizes the trend in Insulet’s return on assets over the last five years:
| Fiscal Year | Net Operating Profit After Tax | Average Invested Capital | Return on Invested Capital |
|---|---|---|---|
| 2020-12-31 | $42.745 M | $1.331 B | 3.2% |
| 2021-12-31 | $104.6 M | $1.761 B | 5.9% |
| 2022-12-31 | $47.808 M | $1.876 B | 2.5% |
| 2023-12-31 | $173.1 M | $2.045 B | 8.5% |
| 2024-12-31 | $256.4 M | $2.414 B | 10.6% |
Return on Invested Capital is used to evaluate the ability of the company to create value for all its stakeholders, debt and equity. ROIC can be used to benchmark companies within an industry but it is also useful to consider its relationship to the Weighted Average Cost of Capital (WACC).
Since ROIC measures the company’s ability to generate a return on invested capital, and the WACC measures the minimum return required by the company’s capital providers (equity and debt), the difference between ROIC and WACC is referred to as Economic Profit or Excess Return.
Excess Return = Return on Invested Capital - Weighted Average Cost of Capital
The chart above depicts the distribution of return on invested capital for companies operating in the Healthcare sector in the Developed economic region. Over 1,900 companies were considered in this analysis, and 1,826 had meaningful values. The average return on invested capital of companies in the sector is -29.3% with a standard deviation of 43.7%.
Insulet Corporation's Return on Invested Capital of 10.6% ranks in the 90.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,902 |
| Included Constituents | 1,826 |
| Min | -198.1% |
| Max | 23.3% |
| Median | -16.9% |
| Mean | -29.3% |
| Standard Deviation | 43.7% |
You can find companies with similar return on invested capital using this stock screener.